PDF herunterladen
PSYCH up2date 2012; 6(06): 345-360
DOI: 10.1055/s-0032-1305336
Schizophrenien und andere psychotische Störungen

Psychotherapie der Schizophrenie

Roland Vauth
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints Alle Artikel dieser Rubrik
Kernaussagen

Die Verbesserung der Versorgung schizophrener Störungen hat hohe Bedeutung für die Betroffenen aber auch in gesundheits-ökonomischer und volkswirtschaftlicher Hinsicht. Neben einer individuell zugeschnittenen möglichst wirksamen und verträglichen antipsychotischen Pharmakotherapie gibt es eine zunehmende Anzahl als wirksam belegter, störungs- und problemspezifischer psychotherapeutischer Ansätze. Hier finden sich v. a. kognitiv-verhaltenstherapeutische Techniken, die in ihrer Wirksamkeit am stärksten belegt sind, v. a. bei trotz Pharmakotherapie persistierender Restsymptomatik. Weitere psychotherapeutische Ansätze, z. T. überlappend, sind die Compliance Therapy, die Personal Therapy, die Acceptance and Commitment Therapy, sog. supportive Behandlungsansätze oder auch metakognitive Therapie, narrative Therapien und Mindfulness-Therapie. Diese Ansätze haben, grob gesprochen, zum Ziel, emotionale Unterstützung im Streben nach einem trotz Erkrankung und evtl. Folgebeeinträchtigungen sinnerfüllten Leben anzubieten (Personal Recovery), die Rollenfunktionsfähigkeit und Selbststeuerung (Functional Recovery) sowie die Symptomatik und die ihr zugrunde liegenden Fehlfunktionen zu verbessern (z. B. persistierende Positivsymptomatik, kognitive oder emotionale Verarbeitungsstörungen).



Publikationsverlauf

Publikationsdatum:
30. Oktober 2012 (online)

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur

  • 1 Tandon R, Keshavan MS, Nasrallah HA. et al. Schizophrenia, “just the facts” what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 2008; 102: 1-18
    CrossrefPubMedGoogle Scholar
  • 2 Wittchen HU, Jacobi F, Rehm J. et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 655-679
    CrossrefPubMedGoogle Scholar
  • 3 Gustavsson A, Svensson M, Jacobi F. et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 718-779
    CrossrefPubMedGoogle Scholar
  • 4 Emsley R, Chiliza B, Asmal L. et al. The concepts of remission and recovery in schizophrenia. Curr Opin Psychiatry 2011; 24: 114-121
    PubMedGoogle Scholar
  • 5 Stauffer VL, Case M, Kinon BJ. et al. Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. Psychiatry Res 2011; 187: 42-48
    CrossrefPubMedGoogle Scholar
  • 6 Leucht S, Heres S, Kissling W. et al. Evidence-based pharmacotherapy of schizophrenia. Int J Neuropsychopharmacol 2011; 14: 269-284
    CrossrefPubMedGoogle Scholar
  • 7 Levine SZ, Lurie I, Kohn R. et al. Trajectories of the course of schizophrenia: From progressive deterioration to amelioration over three decades. Schizophr Res 2011; 126: 184-191
    CrossrefPubMedGoogle Scholar
  • 8 Lysaker PH, Roe D, Buck KD. Recovery and wellness amidst schizophrenia: definitions, evidence, and the implications for clinical practice. J Am Psychiatr Nurses Assoc 2010; 16: 36-42
    CrossrefPubMedGoogle Scholar
  • 9 Vauth R, Cavelti M, Schieting S. et al. Recovery bei schizophrenen Störungen: Ergebnis und Prozess im Fokus moderner Behandlung. Schizophrenie. Mitteilungen der gfts 2011; 27: 50-57
    Google Scholar
  • 10 Warner R. Recovery from schizophrenia and the recovery model. Curr Opin Psychiatry 2009; 22: 374-380
    CrossrefPubMedGoogle Scholar
  • 11 Lipskaya L, Jarus T, Kotler M. Influence of cognition and symptoms of schizophrenia on IADL performance. Scand J Occup Ther 2010; 18: 180-187
    CrossrefPubMedGoogle Scholar
  • 12 Tsang HW, Leung AY, Chung RC. et al. Review on vocational predictors: a systematic review of predictors of vocational outcomes among individuals with schizophrenia: an update since 1998. Aust NZ J Psychiatry 2010; 44: 495-504
    PubMedGoogle Scholar
  • 13 Conley RR, scher-Svanum H, Zhu B. et al. The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophrenia Research 2007; 90: 186-197
    CrossrefPubMedGoogle Scholar
  • 14 Vauth R. Psychologische Mechanismen bei der Entwicklung von Depression und ihre Implikationen für psychotherapeutische Ansatzpunkte bei schizophrenen Störungen. Neuro Aktuell 2012; 1: 26-29
    Google Scholar
  • 15 Beck EM, Cavelti M, Kvrgic S. et al. Are we addressing the “right stuff” to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication. Schizophr Res 2012; 132: 42-49
    CrossrefPubMedGoogle Scholar
  • 16 Cavelti M, Kvrgic S, Beck EM. et al. Self-stigma and its relationship with insight, demoralization, and clinical outcome among people with schizophrenia spectrum disorders. Compr Psychiatry 2011; 53: 468-479
    CrossrefPubMedGoogle Scholar
  • 17 Lencer R, Harris MSH, Weiden PJ. et al. When psychopharmacology is not enough: Using cognitive behavioral therapy techniques for persons with persistent psychosis. Göttingen: Hogrefe; 2011
    Google Scholar
  • 18 Vauth R, Stieglitz RD. Chronisches Stimmenhören und persistierender Wahn. Fortschritte der Psychotherapie. Göttingen: Hogrefe; 2007
    Google Scholar
  • 19 Vauth R, Kleim B, Wirtz M. et al. Self-efficacy and empowerment as outcomes of self-stigmatizing and coping in schizophrenia. Psychiatry Research 2007; 150: 71-80
    CrossrefPubMedGoogle Scholar
  • 20 Vauth R, Stieglitz RD. Compliance-Aufbau im Fokus der Schizophreniebehandlung. Z Psychiatrie Psychol Psychother 2010; 58: 119-125
    Google Scholar
  • 21 Garety PAB, Fowler P, Freeman D. et al. Implications for neurobiological research of cognitive models of psychosis: a theoretical paper. Psychological Medicine 2007; 37: 1377-1391
    CrossrefPubMedGoogle Scholar
  • 22 Kuipers E, Garety P, Fowler D. et al. Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms. Schizophrenia Bulletin 2006; 32 (Suppl. 01) S24-S31
    CrossrefPubMedGoogle Scholar
  • 23 Rector NA, Beck AT. Cognitive behavioral therapy for schizophrenia: an empirical review. [Review] [70 refs]. Journal of Nervous & Mental Disease 2001; 189: 278-287
    CrossrefPubMedGoogle Scholar
  • 24 Rathod S, Phiri P, Kingdon D. Cognitive behavioral therapy for schizophrenia. Psychiatr Clin North Am 2010; 33: 527-536
    CrossrefPubMedGoogle Scholar
  • 25 Tarrier N. Cognitive behavior therapy for schizophrenia and psychosis: current status and future directions. Clin Schizophr Relat Psychoses 2010; 4: 176-184
    CrossrefPubMedGoogle Scholar
  • 26 Miklowitz DJ, Otto MW, Frank E. et al. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry 2007; 164: 1340-1347
    CrossrefPubMedGoogle Scholar
  • 27 Vauth R. Psychotherapie bei schizophrenen Störungen auf der Grundlage modernen Case Managements. In: Falkai P, Pajonk FG. Hrsg. Langzeittherapie der Schizophrenie. Bremen: Unimed; 2004: 84-97
    Google Scholar
  • 28 Vauth R. Wirksame Konzepte in der multimodalen Verhaltenstherapie bei schizophrenen Störungen: Ziele und Strategien. Psychodynam Psychother 2012; 11: 51-62
    Google Scholar
  • 29 Cather C. Functional cognitive-behavioural therapy: a brief, individual treatment for functional impairments resulting from psychotic symptoms in schizophrenia. Can J Psychiatry 2005; 50: 258-263
    CrossrefPubMedGoogle Scholar
  • 30 Dickerson FB, Lehman AF. Evidence-based psychotherapy for schizophrenia: 2011 update. J Nerv Ment Dis 2011; 199: 520-526
    CrossrefPubMedGoogle Scholar
  • 31 Gaudiano BA, Herbert JD. Acute treatment of inpatients with psychotic symptoms using Acceptance and Commitment Therapy: Pilot results. Behav Res Ther 2006; 44: 415-437
    CrossrefPubMedGoogle Scholar
  • 32 Tarrier N, Wykes T. Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale?. Behav Res Ther 2004; 42: 1377-1401
    CrossrefPubMedGoogle Scholar
  • 33 Wykes TSC, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin 2008; 34: 523-537
    PubMedGoogle Scholar
  • 34 Zimmermann G, Favrod J, Trieu VH. et al. The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis. Schizophrenia Res 2005; 77: 1-9
    CrossrefPubMedGoogle Scholar
  • 35 Startup M, Jackson MC, Evans KE. et al. North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation. Psychol Med 2005; 35: 1307-1316
    CrossrefPubMedGoogle Scholar
  • 36 Vauth R. Gruppenpsychotherapeutische Interventionen bei schizophrenen Störungen. In: Strauß B, Mattke D. Hrsg. Gruppenpsychotherapie. Lehrbuch für die Praxis. Heidelberg: Springer; 2012: 367-376
    Google Scholar
  • 37 Wykes T, Parr AM, Landau S. Group treatment of auditory hallucinations. Exploratory study of effectiveness. Br J Psychiatry 1999; 175: 180-185
    CrossrefPubMedGoogle Scholar
  • 38 Granholm E, McQuaid JR, McClure FS. et al. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. Am J Psychiatry 2005; 162: 520-529
    CrossrefPubMedGoogle Scholar
  • 39 Granholm E, McQuaid JR, McClure FS. et al. Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up. J Clin Psychiatry 2007; 68: 730-737
    CrossrefPubMedGoogle Scholar
  • 40 Lysaker PH, Davis LH, Bryson GJ. et al. Effects of cognitive behavioral therapy on work outcomes in vocational rehabilitation for participants with schizophrenia spectrum disorders. Schizophrenia Research 2009; 107: 186-191
    CrossrefPubMedGoogle Scholar
  • 41 Velligan DI, Draper M, Stutes D. et al. Multimodal Cognitive Therapy: Combining Treatments That Bypass Cognitive Deficits and Deal With Reasoning and Appraisal Biases. Schizophrenia Bulletin 2009; 35: 884-893
    CrossrefPubMedGoogle Scholar
  • 42 Kemp R, David A, Haywood P. Compliance therapy: an intervention targeting insight and treatment adherence in psychotic patients. Behav Cognitive Psychother 1996; 24: 331-350
    CrossrefGoogle Scholar
  • 43 Kemp R, Hayward P, Applewhaite G. et al. Compliance therapy in psychotic patients: randomised controlled trial. Br Med J 1996; 312: 345-349
    CrossrefPubMedGoogle Scholar
  • 44 Kemp R, Kirov G, Everitt B. et al. Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry 1998; 172: 413-419
    CrossrefPubMedGoogle Scholar
  • 45 O'Donnell C, Donohoe G, Sharkey L. et al. Compliance therapy: a randomised controlled trial in schizophrenia. Br Med J 2003; 327: 834
    CrossrefPubMedGoogle Scholar
  • 46 Anderson KH, Ford S, Robson D. et al. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia. Int J Ment Health Nurs 2010; 19: 340-349
    CrossrefPubMedGoogle Scholar
  • 47 Hogarty GE, Greenwald D, Ulrich RF. et al. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. Am J Psychiatry 1997; 154: 1514-1524
    CrossrefPubMedGoogle Scholar
  • 48 Hogarty GE, Kornblith SJ, Greenwald D. et al. Personal therapy: a disorder-relevant psychotherapy for schizophrenia. Schizophrenia Bulletin 1995; 21: 379-393
    CrossrefPubMedGoogle Scholar
  • 49 Hofmann SG, Asmundson GJ. Acceptance and mindfulness-based therapy: new wave or old hat?. Clin Psychol Rev 2008; 28: 1-16
    CrossrefPubMedGoogle Scholar
  • 50 Ost LG. Efficacy of the third wave of behavioral therapies: a systematic review and meta-analysis. Behav Res Ther 2008; 46: 296-321
    CrossrefPubMedGoogle Scholar
  • 51 Bach P, Hayes SC. The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial. J Consult Clin Psychol 2002; 70: 1129-1139
    CrossrefPubMedGoogle Scholar
  • 52 Moritz S, Veckenstedt R, Randjbar S. et al. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms. Psychol Med 2011; 41: 1823-1832
    CrossrefPubMedGoogle Scholar
  • 53 Moritz S, Vitzthum F, Randjbar S. et al. Detecting and defusing cognitive traps: metacognitive intervention in schizophrenia. Curr Opin Psychiatry 2010; 23: 561-569
    CrossrefPubMedGoogle Scholar
  • 54 Bentall RP, Rowse G, Shryane N. et al. The cognitive and affective structure of paranoid delusions: a transdiagnostic investigation of patients with schizophrenia spectrum disorders and depression. Arch Gen Psychiatry 2009; 66: 236-247
    CrossrefPubMedGoogle Scholar
  • 55 Mackinnon K, Newman-Taylor K, Stopa L. Persecutory delusions and the self: An investigation of implicit and explicit self-esteem. J Behav Ther Exp Psychiatry 2011; 42: 54-64
    CrossrefPubMedGoogle Scholar
  • 56 Aghotor J, Pfueller U, Moritz S. et al. Metacognitive training for patients with schizophrenia (MCT): feasibility and preliminary evidence for its efficacy. J Behav Ther Exp Psychiatry 2010; 41: 207-211
    CrossrefPubMedGoogle Scholar
  • 57 Vauth R. Der therapeutische Umgang mit persistierender Positivsymptomatik. In: Steinberg R. Hrsg. Psychosentherapie. Regensburg: Roderer; 2003
    Google Scholar
  • 58 Kingdon D, Turkington D, John C. Cognitive behaviour therapy of schizophrenia. The amenability of delusions and hallucinations to reasoning. Br J Psychiatry 1994; 164: 581-587
    CrossrefPubMedGoogle Scholar
  • 59 Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 1997; 23: 637-651
    CrossrefPubMedGoogle Scholar
  • 60 Zygmunt A, Olfson M, Boyer CA. et al. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002; 159: 1653-1664
    CrossrefPubMedGoogle Scholar
  • 61 Velligan DI, Weiden PJ, Sajatovic M. et al. Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines. J Psychiatr Pract 2010; 16: 306-324
    CrossrefPubMedGoogle Scholar
  • 62 Vauth R, Bull N, Schneider G. Emotions- und stigmafokussierte Angehörigenarbeit bei psychotischen Störungen. Ein Behandlungsprogramm mit DVD. Göttingen: Hogrefe; 2009
    Google Scholar
  • 63 Behrendt B. Meine persönlichen Warnsignale. Tübingen: dgvt-Verlag; 2001
    Google Scholar
  • 64 Pharoah F, Mari J, Rathbone J. et al. Family intervention for schizophrenia. Cochrane Database Syst Rev. 2010; 12: CD000088
    Google Scholar
  • 65 Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia?. American Journal of Psychiatry 1996; 153: 321-330
    CrossrefPubMedGoogle Scholar
  • 66 Smith T, Hull J, Romanelli S. et al. Symptoms and neurocognition as rate limiters in skills training for psychotic patients. Am J Psychiatry 1999; 156: 1817-1818
    CrossrefPubMedGoogle Scholar
  • 67 Cook JA, Razzano L. Vocational rehabilitation for persons with schizophrenia: recent research and implications for practice. Schizophrenia Bulletin 2000; 26: 87-104
    CrossrefPubMedGoogle Scholar
  • 68 Vauth R, Stieglitz RD. Das Training Emotionaler Intelligenz bei schizophrenen Störungen. Soziale Kognition und emotionale Verarbeitung im Fokus erfolgreicher Rehabilitation. Göttingen: Hogrefe; 2008
    Google Scholar
  • 69 Bustillo J, Lauriello J, Horan W. et al. The psychosocial treatment of schizophrenia: an update. Am J Psychiatry 2001; 158: 163-175
    CrossrefPubMedGoogle Scholar
  • 70 Heinssen RK, Liberman RP, Kopelowicz A. Psychosocial skills training for schizophrenia: lessons from the laboratory. Schizophrenia Bulletin 2000; 26: 21-46
    CrossrefPubMedGoogle Scholar
  • 71 Liberman RP, Wallace CJ, Blackwell G. et al. Training social and independent living skills: Applications and impact in chronic schizophrenia. In: Cottraux J, Legeron P, Mollard E. eds. Which psychotherapies in the year 2000? Annual series of European research in behavior therapy. Vol. 6. Amsterdam, Netherlands: Swets & Zeitlinger; 1992: 65-85
    Google Scholar
  • 72 Roder V, Mueller DR, Schmidt SJ. Effectiveness of integrated psychological therapy (IPT) for schizophrenia patients: a research update. Schizophr Bull 2011; 37: 71-79
    CrossrefPubMedGoogle Scholar
  • 73 Vauth R, Corrigan PW, Dietl M. et al. Cognitive strategies versus self-management skills as adjunct to vocational rehabilitation. Schizophrenia Bulletin 2005; 31: 55-66
    CrossrefPubMedGoogle Scholar
  • 74 Wykes T, Steel C, Everitt B. et al. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008; 34: 523-537
    CrossrefPubMedGoogle Scholar
  • 75 Rector NA, Hood K, Richter MA. et al. Obsessive-compulsive disorder and the five-factor model of personality: Assessing the distinction and overlap with major depressive disorder. Behav Res Ther 2002; 40: 1205-1219
    CrossrefPubMedGoogle Scholar
  • 76 Birchwood M, Meaden A, Trower P. et al. The power and omnipotence of voices: subordination and entrapment by voices and significant others. Psychol Med 2000; 30: 337-344
    CrossrefPubMedGoogle Scholar